← Product Code QSY · K130324 # STATSEAL DISC (K130324) _Biolife, LLC · QSY · Jul 9, 2013 · SU · SESE_ **Canonical URL:** https://fda.innolitics.com/device/K130324 ## Device Facts - **Applicant:** Biolife, LLC - **Product Code:** QSY - **Decision Date:** Jul 9, 2013 - **Decision:** SESE - **Submission Type:** Traditional - **Device Class:** Class U - **Review Panel:** SU - **Attributes:** Therapeutic ## Intended Use OTC: StatSeal Disc is intended for OTC use as a topical dressing for bleeding control associated with minor wounds, for temporary external control of minor bleeding from minor wounds, minor cuts, minor lacerations and minor burns. Rx: StatSeal Disc is intended under the care of a health care professional for external temporary control of bleeding from percutaneous needle access, vascular access sites and percutaneous catheters. ## Device Story StatSeal Disc is a topical hemostatic dressing; composed of potassium ferrate and hydrophilic polymer. Device functions by creating physical barrier/seal; induces hemostasis via fluid dehydration, protein coagulation, and agglomeration. Used in clinical settings by healthcare professionals for vascular access sites; also available OTC for minor wounds/cuts/burns. Applied topically to bleeding site; absorbs body fluids; provides temporary external bleeding control. Benefits patient by rapidly stopping bleeding at access sites or minor wounds. Sterile, single-use device. ## Clinical Evidence Bench testing included absorption studies, SEM comparison, hemostatic property evaluation, disintegration, and friability studies. In-vivo testing consisted of a comparative study evaluating vascular access hemostasis properties in Göttingen minipigs. Biocompatibility testing was leveraged from the predicate device (PRO QR Powder) due to identical composition. ## Technological Characteristics Composed of potassium ferrate and hydrophilic polymer. Functions as a hemostatic disc wound dressing. Sterile, single-use device. Mechanism involves fluid dehydration, protein coagulation, and agglomeration to create a physical barrier. ## Regulatory Identification To temporarily control bleeding and cover external wounds. ## Predicate Devices - PRO QR (Quick Relief) Powder ([K080210](/device/K080210.md)) - Hemaderm ([K021678](/device/K021678.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health and Human Services logo on the left and the FDA logo on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. Food & Drug Administration" in blue. April 21, 2023 Biolife, LLC Claudia Masselink Director Quality Assurance 8163 25th Court East Sarasota, Florida 34243 Re: K130324 Trade/Device Name: Statseal Disc Regulatory Class: Unclassified Product Code: QSY Dear Claudia Masselink: The Food and Drug Administration (FDA) is sending this letter to notify you of an administrative change related to your previous substantial equivalence (SE) determination letter dated July 9, 2013. Specifically, FDA is updating this SE Letter because FDA has better categorized your device technology under product code QSY. Please note that the 510(k) submission was not re-reviewed. For questions regarding this letter please contact Julie Morabito, OHT4: Office of Surgical and Infection Control Devices, 240-402-3839, Julie.Morabito@fda.hhs.gov. Sincerely, # Julie A. Morabito -S Julie Morabito, Ph.D. Assistant Director DHT4B: Division of Infection Control and Plastic Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health {1}------------------------------------------------ Image /page/1/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol that resembles a caduceus, with three curved lines representing snakes intertwined around a staff. #### DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-GB19 Silver Spring, MD 20993-002 Biolife, L.L.C. % Ms. Claudia Masselink Director Quality Assurance 8163 25th Court East Sarasota, Florida 34243 Re: K130324 Trade/Device Name: StatSeal Disc Regulatory Class: Unclassified Product Code: FRO Dated: May 09, 2013 Received: May 13, 2013 Dear Ms. Masselink: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act, The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you: however, that device labeling must be truthful and not misleading. If your device is classified (see above) into cither class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA 's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set July 9, 2013 {2}------------------------------------------------ Page 2 – Ms. Claudia Masselink forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm 1 15809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, # Mark N. Melkerson -S Mark N. Melkerson Acting Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ 510(k) Premarket Notification K130324 STATSEA 510(k) Number : K130324 Device Name: StatSeal Disc Indications for Use: #### OTC: StatSeal Disc is intended for OTC use as a topical dressing for bleeding control associated with minor wounds, for temporary external control of minor bleeding from minor wounds, minor cuts, minor lacerations and minor burns. #### Rx: StatSeal Disc is intended under the care of a health care professional for external temporary control of bleeding from percutaneous needle access, vascular access sites and percutaneous catheters. Prescription Use _____________________________________________________________________________________________________________________________________________________________ (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) # Jiyoung Dang -S (Division Sign-Off) Division of Surgical Devices 510(k) Number: K130324 Biolife. L.L.C. 8163 25" Court East, Sarasota, FL 34243 × {4}------------------------------------------------ # 510(k) Premarket Notification K130324 STATSEAL. # 510(k) SUMMARY This section contains the following information: JUL 0 9 2013 · l | Section | Description | Page | |---------|---------------------------|------| | 1 | Sponsor | 2 | | 2 | Date Summary was Prepared | 2 | | 3 | Device Information | 2 | | 4 | Predicate Device | 2 | | 5 | Device Description | 3 | | 6 | Intended Use | 3 | | 7 | Substantial Equivalence | 3 | | 8 | Performance Testing | 4 | | 9 | Conclusion | 4 | : {5}------------------------------------------------ 510(k) Premarket Notification K130324 STATSEAL ## 510(k) SUMMARY ## 1. Sponsor Biolife, LLC 8163 25th Court East Sarasota, FL 34243 Telephone: 941-360-1300 Fax: 941-360-1310 Registration Number: 1066421 Contact Person: Claudia A. Masselink 2. Date Summary was Prepared May 6, 2013 ## 3. Device Information | Proprietary Name: | StatSeal Disc | |----------------------|--------------------------------| | Common Name: | Hemostatic Disc Wound Dressing | | Classification Name: | Dressing, Unclassified | #### 4. Predicate Device Biolife, L.L.C.; PRO QR (Quick Relief) ® Powder (K080210) Hemaderm (K021678) {6}------------------------------------------------ 510(k) Premarket Notification K130324 STATSEAL. #### 5. Device Description Components - StatSeal Disc is composed of two main components: Potassium ferrate, and hydrophilic polymer. Mechanism of Action - StatSeal Disc achieves its principle intended action (hemostasis) by creating a physical barrier or seal to the blood flow. #### 6. Intended Use OTC: StatSeal Disc is intended for OTC use as a topical dressing for bleeding control associated with minor wounds, for temporary external control of minor bleeding from minor wounds, minor cuts, minor lacerations and minor burns. Rx: StatSeal Disc is intended under the care of a health care professional for external temporary control of bleeding from percutaneous needle access, vascular access sites and percutaneous catheters. #### 7. Substantial Equivalence StatSeal Disc has substantially equivalent claims to Biolife, L.L.C.; PRO QR (Quick Relief) ® Powder (K080210) predicate, in that it is indicated for topical application as an aid in the control of minor bleeding wounds. StatSeal Disc uses the same safe and effective technology as PRO QR (Quick Relief) ® Powder (K080210). The subject and predicate are identical devices. They are made from materials which have demonstrated satisfactory biocompatibility, are highly absorbent for collecting body fluids, and are sterile, single use devices. {7}------------------------------------------------ # 510(k) Premarket Notification K130324 STAT SEAL. StatSeal Disc has identical claims to the HemaDerm (K021678) predicate in that it is intended to be applied to a vascular access site to control bleeding. Both HemaDerm and StatSeal Disc share a mechanism of action i.e. both products rapidly dehydrate blood. ### 8. Performance Testing ### Biocompatibility Testing: All required biocompatibility testing was conducted on PRO QR Powder (K080520) with no adverse results. StatSeal Disc and PRO QR Powder have identical composition therefore no change in biocompatibility is expected. #### In vitro Testing: Absorption Study, Scanning Electron Microscopy (SEM) Comparison, Hemostatic Properties of StatSeal Disc, Disintegration Study, Friability Study. #### In-vivo Testing: A comparative Study Evaluating Vascular Access Hemostasis Properties of StatSeal Disc in GottinGen Minipigs. #### 9. Conclusion StatSeal Disc has the same intended use as the PRO QR Powder and HemaDerm predicate devices. StatSeal Disc raises no issues of safety or effectiveness. StatSeal Disc induces hemostasis by fluid dehydration, protein coagulation and agglomeration. Biolife, LLC believes that, StatSeal Disc is safe and effective for temporary external control of minor bleeding from minor wounds, and for temporary external control of bleeding from percutaneous needle access, vascular access sites and percutaneous catheters. --- **Source:** [https://fda.innolitics.com/device/K130324](https://fda.innolitics.com/device/K130324) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com